Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;14(1):23-28.
doi: 10.5114/jcb.2022.113425. Epub 2022 Feb 8.

Is perioperative brachytherapy effective in carcinoma of the tongue?

Affiliations

Is perioperative brachytherapy effective in carcinoma of the tongue?

Miguel Santos et al. J Contemp Brachytherapy. 2022 Feb.

Abstract

Purpose: To analyze the results of patients treated with perioperative interstitial brachytherapy (ISBT) in tongue carcinoma (TC).

Material and methods: From April 2009 to May 2015, 43 squamous cell carcinoma consecutive patients diagnosed with TC were treated with limited partial glossectomy and perioperative ISBT, using high-dose-rate (HDR). Twenty- seven patients were treated by brachytherapy (BT), and sixteen received BT as a complement to subsequent external beam radiotherapy (EBRT) after results of lymph node dissection. Median age was 66 years. Distribution by stage, included 10 patients stage I, 14 stage II, 10 stage III, and 9 stage IV. Eighteen patients had negative margins, nineteen margin involvement, and in six cases, the margin was < 5 mm.

Results: With a median follow-up of 54 months, LC at 3 and 5 years was 87% and 84%, respectively. LC was 95% at five years in patients with clear margins, and 75% with involved margins. LC in N0 patients treated with BT was 83% at 5 years, and in patients N+ with posterior EBRT treatment, LC was 86%. By tumor size, we found one local relapse in 13 cases T1, in 5 of 27 patients T2 was found, and no local relapse T3 with LC of 87%, 70%, and 100% respectively at five years. Regional control (RC) was 81% at 3 and 5 years. We found a metastasis-free survival of 91% at 3- and 5-year. Twenty-three patients have died, 11 of them due to other causes, with overall survival of 56% at three years and 53% at five years.

Conclusions: Combined treatment with conservative surgery and ISBT shows similar results to radical surgery or RT alone, allowing a more patient-tailored approach, with good organ function preservation and cosmetic outcomes.

Keywords: brachytherapy; high-dose-rate; perioperative; tongue carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Figures

Fig. 1
Fig. 1
CT planning scan, with manual adjustment of isodoses curves to decrease the dose to 0.1 cc of the mandible under pre- scription dose, keeping a DNR (V150/V100) under 0.35 (in this case, 0.27)
Fig. 2
Fig. 2
Kaplan-Meier local control probability
Fig. 3
Fig. 3
Local control probability according to margins status, negative or positive
Fig. 4
Fig. 4
Local control probability according to margins sta- tus: positive, negative, or close
Fig. 5
Fig. 5
Comparison of two patients, at rest and with maximum protrusion of the tongue. A) Hemiglossectomy with a graft. B) Partial glossectomy and perioperative BT (close margin, 10 × 4 Gy). Patient included in this study at 4 years of follow-up, with better function

References

    1. Ganly I, Patel S, Shah J. Early-stage squamous cell cancer of the oral tongue–clinicopathologic features affecting outcome. Cancer 2012; 118: 101-111. - PubMed
    1. Preis M, Hadar T, Soudry TEet al. . Early tongue carcinoma: analysis of failure. Head Neck 2012; 34: 418-421. - PubMed
    1. Hinerman RW, Mendenhall WM, Morris CGet al. . Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 2004; 26: 984-994. - PubMed
    1. Iyer NG, Kim L, Nixon IJet al. . Outcome of patients with early T1 and T2 squamous cell carcinoma of the base of tongue managed by conventional surgery with adjuvant postoperative radiation. Head Neck 2013; 35: 999-1006. - PubMed
    1. Mazeron JJ, Ardiet JM, Haie-Meder Cet al. . GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 2009; 91: 150-156. - PubMed